ursodeoxycholic acid
ursodeoxycholic acid.JPG

CLINICAL USE

Dissolution of gallstones Primary biliary cirrhosis

DOSE IN NORMAL RENAL FUNCTION

Dissolution of gallstones: 8–12 mg/kg/day in 1–2 divided doses Primary biliary cirrhosis: 10–15 mg/kg/day in 2–4 divided doses

PHARMACOKINETICS

  • Molecular weight                           : 392.6
  • %Protein binding                           : 96–98
  • %Excreted unchanged in urine     : 0
  • Volume of distribution (L/kg)       : No data
  • half-life – normal/ESRD (hrs)      : No data

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                : Unknown dialysability. Dose as in normal renal function
  • HD                     : Unknown dialysability. Dose as in normal renal function
  • HDF/high flux   : Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      : Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Ciclosporin: unpredictably increases the absorption of ciclosporin in some patients

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Completely metabolised in the liver and excreted via the faecal route



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs